Near-infrared spectroscopy is one route explored for glucose sensing through tissue, and the infrared filter at the front of the optode is what isolates the wavelengths where glucose and water absorb while rejecting the ambient light that would swamp the weak signal. As wearable optodes shrink, the filter has to hold its band in a tiny, body-worn package. This note looks at how that filter is being specified and sourced for continuous glucose monitoring.
IR Filters in Continuous Glucose Monitoring
A continuous-glucose optode shines near-infrared light into tissue and reads the back-scattered or transmitted spectrum, where glucose and water each leave weak, overlapping absorption features. The infrared filter defines the narrow channels around those features and, just as importantly, blocks the visible and the off-band infrared flooding the skin surface from room light and the sun. Because the glucose signal is tiny against water and against ambient, the filter's band position and blocking are what let the detector see the chemistry at all.
What drives cost and lead time
For a wearable IR filter the cost is set by the band center in the near infrared, the blocking depth across the visible and the off-band infrared, and the small substrate size the optode allows. A narrow bandpass with steep edges and deep blocking costs more than a broadband window, and biocompatible or sealed packaging adds steps. Lead time is shortened when the band set is fixed and standard rather than tuned per build, because the coating house can run it on a known recipe instead of qualifying a new one.
How IR filters works in practice
In practice the part is a small bandpass or a pair of long-pass and short-pass edges in front of an emitter or detector, set near-normal to the beam inside the optode. Its job is to pass the glucose and water feature band while rejecting everything else, and to keep that rejection stable as the wearer moves between indoor and outdoor light. The filter is usually a hard dielectric stack on a tiny substrate, and its performance is judged by how quietly the detector reads when ambient light changes.
Design rules that reduce cost
Keep the band set to the wavelengths the spectroscopy actually uses and resist adding channels that are not independent, because each band is another coating and test step. Use a standard small substrate and relax cosmetic limits outside the active aperture, since the part sits behind a cover, not in the viewed image. Where the optode already rejects visible light electronically, let the detector do that work and specify only the infrared blocking the optics must provide, which trims both cost and lead time.
Standards, documentation and traceability
The number that matters is the measured spectral curve, so each filter should ship with a transmission and blocking curve across the working range and a stated band center and bandwidth. Where the device is a body-worn medical sensor, the filter's material and any coating fall under the device's biocompatibility and regulatory file, referenced under the applicable framework rather than specified in isolation. RoHS and REACH status follow the glass and coating and should be declared against the current official text.
Requirements specific to Continuous Glucose Monitoring
CGM duty adds body-worn size, ambient rejection and a medical regulatory frame to the usual IR-filter constraints. Specify the band at the glucose and water features, hold blocking deep across the visible and off-band infrared so ambient does not swamp the signal, and qualify the part for a small sealed package. Keep a spectral curve per unit for traceability, and treat material biocompatibility and environmental declarations as part of the device file rather than a standalone optical spec.
- Band centered on glucose and water absorption features
- Deep blocking across visible and off-band infrared
- Small sealed package qualified for body-worn use
- Fixed band set to shorten lead time
- Spectral curve per unit for traceability
- Biocompatibility and RoHS in the device file
Framework references: biocompatibility of device materials is addressed under the ISO 10993 framework by the device manufacturer; spectral quantities follow the CIE framework. Filter spectral data and environmental declarations are the supplier's to state against the current official text, not to be assumed, particularly for body-worn medical applications.
Selection data at a glance
| Parameter | Typical value | Notes |
|---|---|---|
| Band center | NIR, per feature | Glucose/water |
| Bandwidth | 5-20 nm typical | Edge controlled |
| Visible blocking | >= OD4 typical | Ambient reject |
| Substrate | Small sealed | Body-worn |
| Uniformity | Across aperture | Wearable |
| Documentation | Curve per unit | Traceability |
Frequently asked questions
Why does blocking matter more than transmission here?
The glucose signal is weak and sits on top of a much stronger water absorption and a flood of ambient light. A few per cent of visible or off-band infrared leaking through can bury the feature, so deep blocking is what makes the measurement possible, while small transmission losses are tolerable.
Can a wearable use the same IR filter as an industrial sensor?
Often the same spectral channel, but the wearable part is smaller, sealed and subject to a medical regulatory file, so biocompatibility and packaging differ. Keep the band identical for consistency, but qualify the part for body-worn use and document it within the device's material file.
Does the filter alone enable non-invasive glucose reading?
No. The filter is one component of a spectroscopy optode; the chemistry, the light path, the calibration model and the regulatory validation carry the real burden. The filter's job is to give the detector a clean, ambient-free channel at the features of interest, not to determine accuracy on its own.
Need a quotation for ir filters?
Send your drawing, target specification or coating requirement and an optical engineer will reply within 24 hours with a price and a lead time.
Request a Quote Email an engineer